Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG | Q16739 | 20/20 | 0.47 |
| ▸ | GBA2 | Q9HCG7 | 20/20 | 0.47 |
| ▸ | GBA1 | P04062 | 19/20 | 0.47 |
| ▸ | LCT | P09848 | 8/20 | 0.47 |
| ▸ | SI | P14410 | 6/20 | 0.47 |
| ▸ | MGAM | O43451 | 4/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25962179 | 0.93 | GBA1 (0.45) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962080 | 0.91 | GBA1 (0.43) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962370 | 0.91 | UGCG (0.44) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962145 | 0.91 | UGCG (0.44) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962156 | 0.88 | GBA1 (0.42) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962272 | 0.87 | UGCG (0.40) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL26219887 | 0.84 | GBA1 (0.43) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962093 | 0.83 | GBA1 (0.42) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL26022198 | 0.83 | GBA1 (0.42) | UGCGGBA2GBA1LCTSI | |
| SCHEMBL25962172 | 0.83 | GBA1 (0.42) | UGCGGBA2GBA1LCTSI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4114826-B1 | CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND | AZAFAROS B V (NL) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023131720-A1 | TREATMENT OF GM2 GANGLIOSIDOSIS | AZAFAROS B.V. (NL) | 2023-07-13 | — | — | WO | disclosed |